Tafinlar is a prescribed medicine. Tafinlar interferes with the growth and spread of cancer cells in the body and is also used to treat certain types of cancer in people who have a ‘BRAF’ gene mutation . It is also used to treat skin cancer (melanoma) , non-small cell lung cancer and thyroid cancer. To buy Tafinlar or to know its price contact Siddha Global.

Manufacturer :- Novartis Pharmaceuticals Corporation.

TAFINLAR DABRAFENIB 50 AND 75 MG

0,00₹

Cantidad

Pack of 120 capsules
Strengths available :- 50 mg and 75 mg

Form :- Capsules

Storage :- Store at 25 ° C

Is the medicine FDA approved :- US FDA Approved

Date of approval :- 29 May , 2013

Dosage :- The recommended dosage regimen of TAFINLAR is 150 mg orally taken twice daily, approximately 12 hours apart as a single agent or with trametinib. Continue treatment until disease progression or unacceptable toxicity occurs.Take TAFINLAR at least 1 hour before or 2 hours after a meal. Do not take a missed dose of TAFINLAR within 6 hours of the next dose of TAFINLAR. Do not open, crush, or break TAFINLAR capsules.

TAFINLAR DABRAFENIB 50 AND 75 MG

PRODUCT INFO

ADDITIONAL INFORMATION

SIDE EFFECTS